Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07581665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effective Dose of Alfentanil Combined With Propofol for Laryngeal Mask Airway Insertion in Children

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 7 more changesShow less
    • Final enrollment: 23 participants (planned 40)
    • Primary completion date changed from estimate of Aug 30, 2026 to Jul 10, 2026
    • Study completion date changed from estimate of Mar 30, 2027 to Jul 11, 2026
    • Start date changed from estimate of May 1, 2026 to May 20, 2026
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 1 of 8 entries
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study uses a prospective, up-and-down sequential allocation method to determine the median effective dose (ED50) and 95% effective dose (ED95) of alfentanil combined with propofol for successful laryngeal mask airway (LMA) insertion in children aged 7-12 undergoing elective day surgery.
Trial Details
NCT Number NCT07581665
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions
(from sponsor)		 Pediatric Anesthesia, Airway Management, General Anesthesia, LMA
Enrollment 23 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov